Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center
暂无分享,去创建一个
F. Bosch | P. Abrisqueta | C. Carpio | M. Carreras | D. Valcárcel | G. Iacoboni | E. Catalá | P. Barba | G. Villacampa | S. Bobillo | A. Pérez | M. Jiménez | A. Farriols | Laura Segura | M. Olivé